Chapter 36
Neurological Problems in Liver Transplantation
M. Guarino,
J. Benito-León,
E. Schmutzhard, K. Weissenborn, J. Decruyenaere, A. Stracciari,
M. Guarino
S. Orsola-Malpighi University Hospital, Bologna, Italy
Search for more papers by this authorJ. Benito-León
University Hospital 12 de Octubre, Madrid, Spain and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
Search for more papers by this authorA. Stracciari
S. Orsola-Malpighi University Hospital, Bologna, Italy
Search for more papers by this authorM. Guarino,
J. Benito-León,
E. Schmutzhard, K. Weissenborn, J. Decruyenaere, A. Stracciari,
M. Guarino
S. Orsola-Malpighi University Hospital, Bologna, Italy
Search for more papers by this authorJ. Benito-León
University Hospital 12 de Octubre, Madrid, Spain and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
Search for more papers by this authorA. Stracciari
S. Orsola-Malpighi University Hospital, Bologna, Italy
Search for more papers by this authorNils Erik Gilhus MD, PhD,
Michael P. Barnes MD, FRCP,
Michael Brainin MD,
Nils Erik Gilhus MD, PhD
Professor
Department of Clinical Medicine, University of Bergen and Department of Neurology, Haukeland University Hospital, Bergen, Norway
Search for more papers by this authorMichael P. Barnes MD, FRCP
Professor of Neurological Rehabilitation Medical Director
University of Newcastle, Hunters Moor Neurorehabilitation Ltd, Newcastle upon Tyne, UK
Search for more papers by this authorMichael Brainin MD
Professor
Department of Clinical Medicine and Prevention, and Center for Clinical Neurosciences, Donau-Universität Krems, Department of Neurology, Landesklinikum Donauregion Tulln Tulln, Austria
Search for more papers by this authorBook Author(s):Nils Erik Gilhus MD, PhD,
Michael P. Barnes MD, FRCP,
Michael Brainin MD,
Nils Erik Gilhus MD, PhD
Professor
Department of Clinical Medicine, University of Bergen and Department of Neurology, Haukeland University Hospital, Bergen, Norway
Search for more papers by this authorMichael P. Barnes MD, FRCP
Professor of Neurological Rehabilitation Medical Director
University of Newcastle, Hunters Moor Neurorehabilitation Ltd, Newcastle upon Tyne, UK
Search for more papers by this authorMichael Brainin MD
Professor
Department of Clinical Medicine and Prevention, and Center for Clinical Neurosciences, Donau-Universität Krems, Department of Neurology, Landesklinikum Donauregion Tulln Tulln, Austria
Search for more papers by this authorSummary
This chapter contains sections titled:
-
Introduction
-
Search strategy
-
Grading of recommendations
-
Results
-
References
References
- Stracciari A, Guarino M. Neuropsychiatric complications of liver transplantation. Metab Brain Dis 2001; 16: 3–11.
- Saner FH, Nadalin S, Radtke A, et al. Liver transplantation and neurological side effects. Metab Brain Dis 2009; 24: 183–7.
- Saner FH, Gu Y, Minouchehr S, et al. Neurological complications after cadaveric and living donor liver transplantation. J Neurol 2006; 253: 612–17.
- Guarino M, Benito-Leon J, Decruyenaere J, Schmutzhard E, Weissenborn K, Stracciari A. EFNS guidelines on management of neurological problems in liver transplantation. Eur J Neurol 2006; 13: 2–9.
- Kim BS, Kim BS, Lee SG, et al. Neurologic complications in adult living donor liver transplant recipients. Clin Transplant 2007; 21: 544–7.
- Saner FH, Sotiropoulos GC, Gu Y, et al. Severe neurological events following liver transplantation. Arch Med Res 2007; 38: 75–9.
- Brainin M, Barnes M, Baron J-C, et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces–revised recommendations. Eur J Neurol 2004; 11: 577–81.
- Jiménez-Pérez M, Lozano Rey JM, Marin Garcia D, et al. Efficacy and safety of monotherapy with mycophenolate mofetil in liver transplantation. Transplant Proc 2006; 38: 2480–1.
- Di Benedetto F, Di Sandro S, De Ruvo N, et al. Sirolimus monotherapy in liver transplantation. Transplant Proc 2007; 39: 1930.
- Dhar R, Young GB, Marotta P. Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy. Neurocrit Care 2008; 8: 253–8.
- Wijdicks EFM, Dahlke LJ, Wiesner RH. Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients. Neurology 1999; 52: 1708–10.
- Gomez R, Moreno E, Loinaz C, et al. Liver transplantation with a twenty-four delay and an initial low dose of cyclosporine. Hepato-Gastroenterology 1996; 43: 435–9.
-
Trzepacz PT, Gupta B, Di Martini A. Pharmacologic issues in organ transplantation: psychopharmacology and neuropsychiatric medication side effects. In: Trzepacz PT, Di Martini A (eds) The Transplant Patient. Cambridge, UK: Cambridge University Press, 2000; pp. 187–213.
10.1017/CBO9780511544385.008 Google Scholar
- Prescott WA Jr, Callahan BL, Park JM. Tacrolimus toxicity associated with concomitant metoclopramide therapy. Pharmacotherapy 2004; 24: 532–7.
- Appignani BA, Bhadella RA, Blacklow SC, Wang AK, Roland SF, Freeman RB. Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. Am J Roentgenol 1996; 166: 683–8.
- Bianco F, Fattaposta F, Locuratolo N, et al. Reversible diffusion MRI abnormalities and transient mutism after liver transplantation. Neurology 2004; 62: 981–3.
- Zivkovic S. Neuroimaging and neurologic complications after organ transplantation. J Neuroimaging 2007; 17: 210–23.
- Pratschke J, Neuhaus R, Tullius SG, et al. Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation. Transplantation 1997; 64: 938–40.
- Abouljoud MS, Kumar MS, Brayman KL, Emre S, Bynon JS; OLN Study Group. Neoral rescue therapy in transplant patients with intolerance to tacrolimus. Clin Transplant 2002; 16: 168–72.
- McAlister VC, Peltekian KM, Malatjalian DA, et al. Orthotopic liver transplantation using low-dose tacrolimus and sirolimus. Liver Transpl 2001; 7: 701–8.
- Yu S, He X, Yang L, et al. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Exp Clin Transplant 2008; 6: 113–17.
- Forgacs B, Merhav HJ, Lappin J, Mieles L. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. Transplant Proc 2005; 37: 1912–14.
- Al Masri O, Fathallah W, Quader S. Recovery of tacrolimus- associated brachial neuritis after conversion to everolimus in a pediatric renal transplant recipient–case report and review of the literature. Pediatr Transplant 2008; 12: 914–17.
- Ravaioli M, Guarino M, Stracciari A, et al. Speech disorder related to tacrolimus-induced pontine myelinolysis after orthotopic liver transplantation. Transpl Int 2003; 16: 605–7.
- Bartynski WS, Tan HP, Boardman JF, Shapiro R, Marsh JW. Posterior reversible encephalopathy syndrome after solid organ transplantation. Am J Neuroradiol 2008; 29: 924–30.
- Casanova B, Prieto M, Deya E, et al. Persistent cortical blindness after cyclosporine leukoencephalopathy. Liver Transpl Surg 1997; 3: 638–40.
- De Weerdt A, Claeys KG, De Jonghe P, et al. Tacrolimus-related polyneuropathy: case report and review of the literature. Clin Neurol Neurosurg 2008; 110: 291–4.
- Rozen TD, Wijdicks EFM, Hay JH. Treatment-refractory cyclosporine-associated headache. Relief with conversion to FK-506. Neurology 1996; 47: 1347.
- Kiemeneij IM, de Leeuw FE, Ramos LM, van Gijn J. Acute headache as a presenting symptom of tacrolimus encephalopathy. J Neurol Neurosurg Psychiatry 2003; 74: 1126–7.
- Toth CC, Burak K, Becker W. Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution. Headache 2005; 45: 245–54.
- Stracciari A, D'Alessandro R, Baldin E, Guarino M. Post-transplant headache: benefit from riboflavin. Eur Neurol 2006; 56: 201–3.
- Rossi SJ, Schroeder TJ, Hariharan S, First MR. Prevention and management of the adverse effects associated with immunosuppressive therapy. Drug Saf 1993; 9: 104–31.
- Rosener M, Martin E, Zipp F, Dichgans J, Martin R. Neurological side-effects of pharmacologic corticoid therapy. Nervenarzt 1996; 67: 983–6.
- Choi EJ, Kang JK, Lee SA, Kim KH, Lee SG, Andermann F. New-onset seizures after liver transplantation: clinical implications and prognosis in survivors. Eur Neurol 2004; 52: 230–6.
- Wijdicks EFM, Plevak DJ, Wiesner RH, Steers JL. Causes and outcome of seizures in liver transplant recipients. Neurology 1996; 47: 1523–5.
- Wszolek ZK, Steg RE. Seizures after orthotopic liver transplantation. Seizure 1997; 6: 31–9.
- Scottish Intercollegiate Guidelines Network–SIGN. Diagnosis and management of epilepsy in adults, 2004.
- Sevmis S, Karakayali H, Emiroglu R, Akkoc H, Haberal M. Tacrolimus-related seizure in the early postoperative period after liver transplantation. Transplant Proc 2007; 39: 1211–13.
- Glass GA, Stankiewicz J, Mithoefer A, Freeman R, Bergethon PR. Levetiracetam for seizures after liver transplantation. Neurology 2005; 64: 1084–5.
- Chabolla DR, Harnois DM, Meschia JF. Levetiracetam monotherapy for liver transplant patients with seizures. Transplant Proc 2003; 35: 1480–1.
- Chabolla DR, Wszolek ZK. Pharmacologic management of seizures in organ transplant. Neurology 2006; 67: S34–8.
- Abbasoglu O, Goldstein RM, Vodapally MS, et al. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant 1998; 12: 263–9.
- Yu J, Zheng SS, Liang TB, Shen Y, Wang WL, Ke QH. Possible causes of central pontine myelinolysis after liver transplantation. World J Gastroenterol 2004; 10: 2540–3.
- Bibl D, Lampl C, Gabriel C, et al. Treatment of central pontine myelinolysis with therapeutic plasmapheresis. Lancet 1999; 353: 1155.
- Saner FH, Koeppen S, Meyer M, et al. Treatment of central pontine myelinolysis with plasmapheresis and immunoglobulins in liver transplant patient. Transpl Int 2008; 21: 390–1.
- Oya S, Tsutsumi K, Ueki K, Kirino T. Reinduction of hyponatremia to treat central pontine myelinolysis. Neurology 2001; 57: 1931–2.
- Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry 2004; 75 (Suppl. 3): 22–8.
- Ruzek KA, Campeau NG, Miller GA. Early diagnosis of central pontine myelinolysis with diffusion-weighted imaging. Am J Neuroradiol 2004; 25: 210–13.
- Bronster DJ, Emre S, Boccagni P, Sheiner PA, Schwartz ME, Miller CM. Central nervous system complications in liver transplant recipients–incidence, timing, and long-term follow-up. Clin Transplant 2000; 14: 1–7.
- Guo Y, Hu JH, Lin W, Zheng KH. Central pontine myelinolysis after liver transplantation: MR diffusion, spectroscopy and perfusion findings. Magn Reson Imaging 2006; 24: 1395–8.
- Campellone JV, Lacomis D. Neuromuscular disorders. In: Wijdicks EFM (ed.) Neurologic Complications in Organ Transplant Recipients. Oxford, UK: Butterworth- Heinemann, 1999; pp. 169–92.
- Mirò O, Salmeron JM, Masanes F, et al. Acute quadriplegic myopathy with myosin-deficient muscle fibres after liver transplantation. Transplantation 1999; 67: 1144–51.
-
Wijdicks EFM, Litchy WJ, Wiesner RH, Krom RA. Neuromuscular complications associated with liver transplantation. Muscle Nerve 1996; 19: 696–700.
10.1002/(SICI)1097-4598(199606)19:6<696::AID-MUS2>3.0.CO;2-5 CAS PubMed Web of Science® Google Scholar
- Rezaiguia-Delclaux S, Lefaucher JP, Zakkouri M, Duvoux C, Duvaldestin P, Stephan F. Severe acute polyneuropathy complicating orthotopic liver allograft failure. Transplantation 2002; 74: 880–2.
- Warner MA. Perioperative neuropathies. Mayo Clin Proc 1998; 73: 567–74.
- Motomura M. Critical illness polyneuropathy and myopathy. Rinsho Shinkeigaku 2003; 43: 802–4.
- Ayres RCS, Dousset B, Wixon S, Buckels JAC, McMaster P, Mayer AD. Peripheral neuropathy with tacrolimus. Lancet 1994; 343: 862–3.
- Bronster DJ, Yonover P, Stein J, Scelsa SN, Miller CM, Sheiner PA. Demyelinating sensorimotor polyneuropathy after administration of FK506. Transplantation 1995; 59: 1066–8.
- El-Sabrout RA, Radovancevic B, Ankoma-Sey V, Van Buren C. Guillain-Barrésyndrome after solid organ transplantation. Transplantation 2001; 71: 1311–16.
- Taylor BV, Wijdicks EFM, Poterucha JJ, Weisner RH. Chronic inflammatory demyelinating polyneuropathy complicating liver transplantation. Ann Neurol 1995; 38: 828–31.
- Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin treatment reduced mortality and morbidity in critically ill patients. N Engl J Med 2001; 345: 1359–67.
- The NICE-SUGAR investigators. Intensive versus Conventional Glucose Control in Critically Ill Patients. N Engl J Med 2009; 360: 1283–97.
- Borg MAJP, van der Wouden E-J, Sluiter WJ, et al. Vascular events after liver transplantation: a long-term follow-up study. Transpl Int 2007; 21: 74–80.
- Ling L, He X, Zeng J, Liang Z. In -hospital cerebrovascular complications following orthotopic liver transplantation: a retrospective study. BMC Neurol 2008; 8: 52.
- Adair JC. Cerebrovascular disorders. In: Wijdicks EFM (ed.) Neurologic Complications in Organ Transplant Recipients. Oxford, UK: Butterworth-Heinemann, 1999; pp. 193–216.
- Singh N, Yu VL, Gayowski T. Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management. Medicine 1994; 73: 110–18.
- Wang WL, Yang ZF, Lo CM, Liu CL, Fan ST. Intracerebral hemorrhage after liver transplantation. Liver Transpl 2000; 6: 345–8.
- Laryea M, Watt KD, Molinari M. Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events. Liver Transpl 2007; 13: 1109–14.
- Tolkoff-Rubin NE, Hovingh KG, Rubin RH. Central nervous system infections. In: Wijdicks EFM (ed.) Neurologic Complications in Organ Transplant Recipients. Boston: Butterworth Heinemann, 1999; pp. 141–68.
- Singh N, Husain S. Infections of the central nervous system in transplant recipients. Transpl Infect Dis 2000; 2: 101–11.
- Roos KL. Infection in solid organ and bone marrow transplant recipients. In: Noseworth JH (ed.) Neurological Therapeutics–Principles and Practice, 2nd edn. Abingdon, Oxon: Informa Health Care, 2006; pp. 1185–95.
- Schmutzhard E, Pfausler B. Infektionen des ZNS beim immunkompetenten Patienten. Nervenarzt 2008; 79: 93–112.
- Noguchi T, Mihara F, Yoshiura T, et al. MR imaging of human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation in adults. Am J Neuroradiol 2006; 27: 2191–5.
- Bonham CA, Dominguez EA, Fukui MB, et al. Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation 1998; 66: 1596–604.
- Portegies P, Solod L, Cinque P, et al. Guidelines for the diagnosis and management of neurological complications of HIV infection. Eur J Neurol 2004; 11: 297–304.
- Stone WJ, Schaffner W. Strongyloides infections in transplant recipients. Semin Respir Infect 1990; 5: 58–64.
- Soave R. Prophylaxis strategies for solid organ transplantation. Clin Infect Dis 2001; 33 (Suppl. 1): 26–31.
- Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000; 30: 710–8.
- Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7–14.
- Bohme A, Ruhnke M, Buchheidt DT, et al. Treatment of fungal infections in hematology and oncology–guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003; 82 (Suppl. 2): S133–40.
- Dewhurst S. Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes 2004; 11 (Suppl. 2): 105A–11A.
- Ruhnke M, Kofla G, Otto K, et al. CNS aspergillosis, recognition, diagnosis and management. CNS Drugs 2007; 21: 659–67.
- Wu G, Vilchez RA, Eidelman B, et al. Cryptococcal meningitis: an analysis among 5521 consecutive organ transplant recipients. Transpl Infect Dis 2002; 4: 183–8.
- Venkataramanan R, Zang S, Gayowski T, Singh N. Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. Antimicrob Agents Chemother 2002; 46: 3091–3.
